VHIO’s Josep Tabernero, Enriqueta Felip, and Ana Oaknin have been recognized as Clarivate Highly Cited 2024
Giuseppe Curigliano shared a post by Vall d’Hebron Institute of Oncology on X:
“Congratulations Josep Tabernero , Enriqueta Felip, Ana Oaknin.”
Quoting Vall d’Hebron Institute of Oncology’s post:
“Congratulations!
We celebrate their achievement and applaud their impactful contributions to cancer research and clinical oncology.”
Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues. He is the Editor-in-Chief of ESMO Open, the European Society for Medical Oncology’s open-access journal.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023